869895-17-0 Usage
Uses
Used in Pharmaceutical Industry:
(4-OXO-CYCLOHEXYLMETHYL)-CARBAMIC ACID BENZYL ESTER serves as a crucial pharmaceutical intermediate, utilized in the development and synthesis of an array of medicinal drugs. Its unique chemical structure allows it to act as a building block or a key component in the formulation of new pharmaceuticals, contributing to the advancement of medical treatments.
Used in Agricultural Industry:
Within the agricultural sector, (4-OXO-CYCLOHEXYLMETHYL)-CARBAMIC ACID BENZYL ESTER may be employed for specific applications, potentially including the development of agrochemicals or as a component in the production of pesticides and herbicides. Its role in this industry could be linked to enhancing crop protection and yield.
Used in Chemical Industry:
In the broader chemical industry, (4-OXO-CYCLOHEXYLMETHYL)-CARBAMIC ACID BENZYL ESTER could be leveraged in various chemical processes and syntheses, given its reactive ester and carbonyl groups. Its applications may span the creation of specialty chemicals, materials, or other intermediates that are essential for different chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 869895-17-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,8,9 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 869895-17:
(8*8)+(7*6)+(6*9)+(5*8)+(4*9)+(3*5)+(2*1)+(1*7)=260
260 % 10 = 0
So 869895-17-0 is a valid CAS Registry Number.
869895-17-0Relevant academic research and scientific papers
COMPOUNDS AS BCL-2 INHIBITORS
-
, (2021/11/13)
Provided are certain Bcl-2 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
2-(Bicyclo)alkylamino-derivatives as mediatores of chronic pain and inflammation
-
Page/Page column 17; 26, (2008/06/13)
Compounds disclosed herein are bradykinin B1 antagonist compounds useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
